We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tesla (TSLA - Free Report) just released its Q3 earnings with record figures on effectively every metric. The innovation-driven automaker just recorded its 5th consecutive profitable quarter.
Elon Musk and his automotive giant are finally keeping their ostentatious promises. Elon promised half a million cars delivered by the end of 2020 and the company might just be able to pull it off.
In the face of a global pandemic and economic recession Tesla was able to deliver a record number of EVs. The enterprise is looking at a very bright future, and it seems that every quarter TSLA’s seemingly lofty valuation is further justified.
Tesla’s Shanghai Gigafactory was a success, and its Berlin Gigafactory is set to start production next summer. Tesla is undoubtedly going to be major automotive driver in the Roaring 20s.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Tesla (TSLA) Blows The Market's Socks Off...Again
Tesla (TSLA - Free Report) just released its Q3 earnings with record figures on effectively every metric. The innovation-driven automaker just recorded its 5th consecutive profitable quarter.
Elon Musk and his automotive giant are finally keeping their ostentatious promises. Elon promised half a million cars delivered by the end of 2020 and the company might just be able to pull it off.
In the face of a global pandemic and economic recession Tesla was able to deliver a record number of EVs. The enterprise is looking at a very bright future, and it seems that every quarter TSLA’s seemingly lofty valuation is further justified.
Tesla’s Shanghai Gigafactory was a success, and its Berlin Gigafactory is set to start production next summer. Tesla is undoubtedly going to be major automotive driver in the Roaring 20s.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>